NuCana

$7.65
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.08 (1.06%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell NuCana and other stocks, options, ETFs, and crypto commission-free!

About NCNA

NuCana Plc engages in the development of technology platform for the treatment of patients with cancer. Its Protide technology is consists of acelarin, NUC-3373, and NUC-7738. Read More The company was founded by Hugh S. Griffith and Christopher B. Wood on January 28, 1997 and is headquartered in Edinburgh, the United Kingdom.

Employees
24
Headquarters
Edinburgh, Midlothian
Founded
1997
Market Cap
242.78M
Price-Earnings Ratio
Dividend Yield
Average Volume
140.53K
High Today
$7.91
Low Today
$7.29
Open Price
$7.33
Volume
93.28K
52 Week High
$26.25
52 Week Low
$4.01

Collections

NCNA News

MarketWatchAug 20

NuCana stock falls 21% after company suspends patient enrollment in pancreatic cancer trial

44

NCNA Earnings

-$21.52
-$14.36
-$7.21
-$0.05
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
-$0.17 per share

More NCNA News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.